Pelvic Inflammatory Disease: Pelvic inflammatory disease (PID) is an acute or chronic inflammation in the pelvic cavity. It is most commonly caused by sexually transmitted diseases, including chlamydia and gonorrhea that have ascended into the uterus, fallopian tubes, or ovaries as a result of intercourse or childbirth, or of surgical procedures, including insertion of IUDs or abortion. PID may be either symptomatic or asymptomatic. It may cause infertility and it may raise the risk of ectopic pregnancy. PID is a disease associated with HIV infection.
Female pelvic inflammatory disorders in diseases classified elsewhere
DOID EFO Endpoint Browser PheWeb
N14_FEMPELINFINOTH
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleonly females |
313377 |
2. Check conditionsNone |
313377 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
147 |
4. Check minimum number of eventsNone |
147 |
5. Include endpointsNone |
147 |
6. Filter based on genotype QC (FinnGen only) |
138 |
Control definitions (FinnGen only)
- Control exclude
- N14_FEMALEGENINF
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Female pelvic inflammatory disorders in diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Inflammatory diseases of female pelvic organs
- Genitourinary diseases
- Any operation in hilmo
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1114 | 1114 | - |
| Only index persons | 1099 | 1099 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | - |
| Only index persons | 0.04 | 0.04 | - |
| Median age at first event (years) | |||
| Whole population | - | 23.59 | - |
| Only index persons | - | 23.53 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 138 | 138 | - |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | - |
| Median age at first event (years) | 24.91 | 24.91 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 143
- Matched controls
- 1430
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N74.4*A56.1
ICD-10 Finland
Female chlamydial pelvic inflammatory disease
+∞
149.4
116
*
N73.9
ICD-10 Finland
Female pelvic inflammatory disease, unspecified
45.7
29.1
35
10
P01AB01
ATC
metronidazole; oral, rectal
6.1
23.0
104
436
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
41.1
22.0
27
8
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
5.2
20.6
61
178
A56.1
ICD-10 Finland
Chlamydial infection of pelviperitoneum and other genitourinary organs
+∞
20.3
19
*
N70.0
ICD-10 Finland
Acute salpingitis and oophoritis
178.7
15.8
16
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
4.1
15.7
83
360
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
4.3
15.5
96
464
N70.1
ICD-10 Finland
Chronic salpingitis and oophoritis
+∞
11.6
11
*
N06AB05
ATC
paroxetine; oral
5.6
11.2
23
47
N74.4
ICD-10 Finland
Female chlamydial pelvic inflammatory disease
+∞
10.5
10
*
N71.9
ICD-10 Finland
Inflammatory disease of uterus, unspecified
25.6
10.5
14
6
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
3.5
10.2
46
172
N02AX02
ATC
tramadol; systemic, rectal
3.1
10.0
65
301
M77.1
ICD-10 Finland
Lateral epicondylitis
4.4
9.3
26
69
J01AA02
ATC
doxycycline; systemic
4.0
8.9
121
832
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
3.3
8.9
43
166
N76.0
ICD-10 Finland
Acute vaginitis
3.7
8.6
32
104
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
3.2
8.6
43
169
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
3.5
8.2
33
113
EBA05
NOMESCO Finland
Complicated extraction of tooth
3.0
8.2
49
213
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.8
8.2
89
529
N05AH04
ATC
quetiapine; oral
3.0
8.1
49
214
TLC00
NOMESCO Finland
Insertion of intrauterine device
3.4
8.0
33
115
R51.80
ICD-10 Finland
Headache
2.8
7.5
49
223
D73
ICPC
Gastroenteritis presumed infection
4.2
7.4
21
56
N73.6
ICD-10 Finland
Female pelvic peritoneal adhesions
+∞
7.3
7
*
M79.6
ICD-10 Finland
Pain in limb
2.6
7.3
82
486
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
3.2
7.1
33
123
R10.0
ICD-10 Finland
Acute abdomen
9.0
7.0
14
17
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.6
7.0
25
79
LCA06
NOMESCO Finland
Biopsy of endometrium
3.2
6.8
31
114
L29
ICD-10 Finland
Pruritus
23.8
6.8
9
*
TLC02
NOMESCO Finland
Simple extraction of IUD
4.1
6.7
20
55
Z72.0
ICD-10 Finland
Tobacco use
9.4
6.7
13
15
O60
ICD-10 Finland
Preterm labour and delivery
4.3
6.7
18
46
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.8
6.6
39
167
N05CF01
ATC
zopiclone; oral
2.7
6.5
45
208
LCH11
NOMESCO Finland
Pharmacologic abortion
3.4
6.5
26
88
P29
ICPC
Psychological sympt/compl other
3.0
6.3
31
119
N70.9
ICD-10 Finland
Salpingitis and oophoritis, unspecified
+∞
6.3
6
*
SPAT1240
SPAT
Therapeutic discussion
2.8
6.3
38
164
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
83
472
2.81
8.39
3.8
2.3
—
—
—
0
0
60
291
2.83
8.21
2.3
2.2
47.51
59.29
u/l
1.54
53
278
85
513
2.62
7.29
3.3
5.3
7.87
9.41
umol/l
1.47
77
489
75
429
2.57
7.15
3.5
2.1
—
—
—
0
0
55
274
2.64
6.94
2.1
2.4
7.79
13.05
ng/l
1.84
19
94
44
216
2.50
5.56
3.3
2.3
2487.88
8073.94
u/l
1.05
18
101
60
343
2.29
5.36
2.4
1.9
—
—
—
0
0
96
684
2.23
4.79
4.5
3.1
0.00
0.00
estimate
-0.00
25
153
96
694
2.17
4.49
4.5
3.1
0.00
0.00
estimate
-0.00
24
151
50
282
2.19
4.48
2.1
1.8
—
—
—
0
0
57
340
2.12
4.42
3.6
2.6
—
—
—
0
0
36
181
2.32
4.22
1.4
1.6
1.44
1.28
%
0.94
29
162
78
531
2.03
4.17
3.9
2.9
0.10
0.01
estimate
0.43
21
130
95
696
2.09
4.13
4.5
3.2
0.00
0.00
estimate
-0.00
25
148
115
921
2.27
3.77
3.4
2.7
52.17
27.40
u/l
0.82
108
893
42
235
2.11
3.77
2.3
2.3
288.16
281.22
umol/l
0.22
37
218
64
418
1.96
3.74
3.5
2.3
0.05
0.01
estimate
0.38
20
127
47
276
2.05
3.70
2.7
2.3
0.42
0.33
e6/l
0.13
32
194
6
9
6.90
2.89
1.0
1.3
—
—
—
0
0
56
376
1.80
2.84
4.6
3.2
0.00
0.00
estimate
-0.00
24
150
8
18
4.64
2.84
1.9
1.3
—
—
—
0
0
82
623
1.74
2.67
3.4
3.9
6.23
6.03
mmol/l
0.39
71
538
126
1095
2.27
2.64
5.4
5.2
14.40
14.21
pmol/l
0.44
119
1051
6
11
5.64
2.57
1.0
1.3
—
—
—
0
0
6
12
5.17
2.42
1.2
1.2
—
—
—
0
0
101
827
1.75
2.40
5.5
6.5
69.62
71.01
u/l
0.18
95
787
5
8
6.43
2.39
3.4
1.9
—
—
—
0
0
135
1239
2.60
2.27
6.4
5.9
1.51
1.65
mu/l
1.00
125
1201
109
920
1.78
2.23
3.9
3.3
7.56
7.94
mm/h
0.23
100
879
128
1143
2.14
2.11
8.5
8.1
99.64
98.02
ml/min/173m2
0.48
116
1021
25
145
1.88
1.97
2.2
2.1
2.26
5.06
e6/l
—
8
62
44
302
1.66
1.97
1.7
1.9
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
11
4.67
1.95
5.4
1.5
100.00
127.45
%
—
5
11
56
414
1.58
1.84
1.3
1.3
0.72
2.11
u/ml
0.97
18
119
63
481
1.55
1.79
2.0
1.6
—
—
—
0
0
17
91
1.99
1.69
1.7
1.4
—
—
—
0
0
14
70
2.11
1.65
2.5
2.5
—
—
—
0
0
13
63
2.17
1.65
1.2
1.4
—
—
—
0
0
26
166
1.69
1.51
2.1
2.0
1.22
0.91
e6/l
—
10
83
5
16
3.20
1.45
1.0
1.0
—
—
—
0
0
53
407
1.48
1.40
3.2
3.1
22.22
25.20
u/l
1.19
46
391
17
98
1.83
1.38
1.5
1.6
—
—
—
0
0
50
381
1.48
1.37
3.2
4.6
1.23
1.22
mmol/l
1.01
43
365
43
320
1.49
1.32
3.6
3.0
1.02
1.02
kg/l
0.65
28
205
5
18
2.84
1.29
1.0
1.1
—
—
—
0
0
115
1041
1.53
1.21
4.7
4.0
36.25
36.21
mmol/mol
0.02
107
1011
6
26
2.36
1.20
1.2
1.1
—
—
—
0
0
41
309
1.46
1.17
1.7
1.8
0.50
0.94
mg/l
1.06
32
229
12
65
1.92
1.17
1.7
1.6
—
—
—
0
0
54
431
1.41
1.13
3.9
5.4
1.23
1.21
mmol/l
1.00
46
386
84
724
1.39
1.11
4.0
7.9
4.62
3.87
e9/l
2.02
74
638
13
74
1.83
1.11
1.2
1.4
—
—
—
0
0
5
21
2.43
1.10
1.0
1.1
—
—
—
0
0
5
21
2.43
1.10
1.0
1.1
—
—
—
0
0
134
1271
1.86
1.06
12.6
9.7
20.93
16.83
mg/l
0.77
120
988
121
1117
1.54
1.05
4.5
3.4
5.43
5.53
mmol/l
0.67
112
1063
40
307
1.42
1.03
1.5
1.4
9.33
30.69
iu/ml
2.11
11
81
16
102
1.64
0.95
1.1
1.4
—
—
—
0
0
6
28
2.19
0.92
4.0
1.9
12.83
13.50
%
—
6
28
126
1182
1.56
0.91
3.8
3.5
4.79
4.73
mmol/l
0.31
120
1153
20
138
1.52
0.87
1.5
1.6
—
—
—
0
0
76
663
1.31
0.84
2.5
2.6
—
—
estimate
—
0
0
6
32
1.91
0.82
1.0
1.3
—
—
—
0
0
15
98
1.59
0.82
1.3
1.4
—
—
—
0
0
61
518
1.31
0.82
1.9
1.8
—
—
—
0
0
13
82
1.64
0.81
2.8
3.9
—
—
—
0
0
6
33
1.85
0.80
1.0
1.2
—
—
—
0
0
0
24
0.00
0.80
0.0
1.4
—
—
—
0
0
8
131
0.59
0.78
1.6
1.6
54.43
51.94
ug/l
—
8
131
13
83
1.62
0.78
3.6
5.8
105.46
105.93
mmol/l
0.18
13
83
125
1180
1.47
0.77
3.8
3.5
1.46
1.52
mmol/l
1.03
118
1146
5
24
2.12
0.75
1.0
1.1
—
—
—
0
0
5
24
2.12
0.75
1.2
1.6
—
—
—
0
0
10
60
1.72
0.74
3.5
2.0
0.04
0.19
e6/l
—
10
55
7
39
1.83
0.73
1.3
2.2
—
—
—
0
0
11
166
0.63
0.69
1.5
1.7
—
—
—
0
0
7
42
1.70
0.69
1.0
1.5
—
—
—
0
0
125
1186
1.43
0.68
4.0
3.7
2.93
2.81
mmol/l
0.91
118
1154
7
44
1.62
0.66
6.4
2.0
0.21
0.24
g/l
—
7
44
5
30
1.69
0.62
1.2
1.1
—
—
—
0
0
11
72
1.57
0.61
1.1
1.9
—
—
—
0
0
42
353
1.27
0.59
2.3
1.9
2.79
2.52
mg/l
0.40
34
324
6
37
1.65
0.56
1.2
2.3
—
—
—
0
0
6
37
1.65
0.56
4.2
2.4
1.37
0.07
mmol/l
—
6
25
35
290
1.27
0.55
1.5
1.3
1.00
8.13
u/ml
—
10
126
19
144
1.37
0.54
2.2
2.0
2.48
2.51
g/l
0.08
13
134
34
282
1.27
0.53
1.5
1.4
18.82
21.57
nmol/l
0.52
27
260
13
93
1.44
0.50
4.8
4.3
0.95
1.02
mmol/l
0.51
13
84
7
48
1.48
0.47
2.1
1.6
101.00
97.62
%
—
7
48
8
55
1.48
0.44
1.5
1.3
—
—
—
0
0
0
17
0.00
0.41
0.0
2.4
—
—
—
0
0
5
34
1.49
0.41
1.0
2.4
2.90
1.31
%
—
5
34
5
35
1.44
0.39
1.2
1.3
—
—
—
0
0
6
47
1.29
0.32
1.0
1.0
—
9.93
—
0
9
44
399
1.15
0.28
3.7
3.9
36.77
37.72
g/l
0.58
38
383
12
97
1.26
0.23
1.3
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
1.04
—
0
5
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
45.19
—
0
12
0
13
0.00
0.21
0.0
4.5
—
14.21
—
0
13
48
449
1.10
0.18
1.6
1.8
91.31
95.30
pmol/l
0.24
26
265
8
68
1.19
0.17
1.8
1.5
—
—
—
0
0
60
570
1.09
0.16
2.3
2.4
73.28
71.11
nmol/l
0.21
55
544
21
189
1.13
0.14
1.2
1.4
—
—
—
0
0
21
190
1.12
0.13
1.2
1.5
0.95
0.95
ratio
0.03
13
124
21
190
1.12
0.13
1.2
1.5
1.43
1.19
ratio
0.46
13
124
21
190
1.12
0.13
1.2
1.5
1.21
1.16
ratio
0.09
13
124
21
190
1.12
0.13
1.3
1.4
282.42
143.98
u/ml
—
6
86
120
1179
1.11
0.13
4.7
4.3
—
—
—
0
0
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
5
45
1.12
0.10
1.0
1.1
—
—
—
0
0
47
489
0.94
0.09
1.7
1.7
1.64
1.30
mmol/l
0.45
38
450
5
63
0.79
0.08
1.6
2.3
—
—
—
0
0
22
235
0.92
0.08
1.8
1.7
3.23
3.20
ratio
0.04
16
175
8
75
1.07
0.07
1.6
1.5
0.40
0.45
nmol/l
—
8
64
9
86
1.05
0.07
2.0
1.0
1.53
1.58
g/l
—
9
86
9
87
1.04
0.07
2.1
1.1
0.99
0.84
g/l
—
9
87
10
91
1.11
0.04
1.9
1.7
5.62
3.05
mg/l
—
10
62
22
230
0.95
0.04
1.5
1.5
—
—
—
0
0
22
213
1.04
0.01
4.9
4.2
4.08
11.52
mg/mmol
1.24
11
143
11
104
1.06
0.01
1.0
1.0
—
—
—
0
0
14
141
0.99
0.00
2.0
1.8
—
—
—
0
0
35
351
1.00
0.00
1.3
1.6
750.15
941.27
mu/l
1.21
29
295
14
145
0.96
0.00
2.2
2.2
3514.20
211.00
ng/l
—
5
52
0
5
0.00
-0.00
0.0
1.8
—
12.14
—
0
5
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
8.30
—
0
9
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.3
—
257.43
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
7.02
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
8.80
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
43.50
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
58.40
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
24.60
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint N14_FEMPELINFINOTH and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have N14_FEMPELINFINOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: N14_FEMPELINFINOTH – Female pelvic inflammatory disorders in diseases classified elsewhere
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data